Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kishan Pandya, MD
University of Rochester, Rochester, NY, USA
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Centre of Southeastern Ontario
Kingston, Ontario, Canada
- Hospital Charles Lemoyne
Greenfield Park, Quebec, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Chelyabinsk Regional Oncology Dispensary
Chelyabinsk, Russia
- Blokhin Cancer Research Center (dept. of Chemotherapy)
Moscow, Russia
- Blokhin Cancer Research Center (dept. of Clinical Pharmacology and Chemotherapy)
Moscow, Russia
- Central Clinical Hospital
Moscow, Russia
- Moscow Oncology Hospital #62
Moscow, Russia
- St. Petersburg City Oncology Center
Saint Petersburg, Russia
- Samara Regional Oncology Center
Samara, Russia
- Regional Oncology Dispensary
Yaroslavl, Russia
- Clinic for Pulmonary Diseases
Belgrade, Serbia
- Clinic for Pulmonary Diseases, Military Medical Academy
Belgrade, Serbia
- Institute for Oncology and Radiology of Serbia
Belgrade, Serbia
- Institute for Pulmonary Diseases of Vojvodina
Kamenitz, Serbia
- Wilshire Oncology Medical Group
La Verne, California, United States
- University of Rochester
Rochester, New York, United States
- Tri-County Hematology & Oncology Associates
Canton, Ohio, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- the Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Pennsylvania Oncology Hematology Associates
Philadelphia, Pennsylvania, United States
- Cancer Specialists of Tidewater
Chesapeake, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2006
- Primary completion
- 29 Feb 2008
- Completion
- 31 May 2008
- Last update posted
- 24 Jul 2014
- Registered enrollment
- 50
- Registry id
- NCT00373204
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.